146 related articles for article (PubMed ID: 17540969)
1. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis.
Williams JE; Chimowitz MI; Cotsonis GA; Lynn MJ; Waddy SP;
Stroke; 2007 Jul; 38(7):2055-62. PubMed ID: 17540969
[TBL] [Abstract][Full Text] [Related]
2. Echocardiography in patients with symptomatic intracranial stenosis.
Kasner SE; Lynn MJ; Jackson BP; Pullicino PM; Chimowitz MI;
J Stroke Cerebrovasc Dis; 2007; 16(5):216-9. PubMed ID: 17845919
[TBL] [Abstract][Full Text] [Related]
3. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.
Kasner SE; Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Benesch CG; Sila CA; Jovin TG; Romano JG; Cloft HJ;
Circulation; 2006 Jan; 113(4):555-63. PubMed ID: 16432056
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
Ovbiagele B; Lynn MJ; Saver JL; Chimowitz MI;
Cerebrovasc Dis; 2007; 24(2-3):283-8. PubMed ID: 17646693
[TBL] [Abstract][Full Text] [Related]
5. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG;
N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis.
Waddy SP; Cotsonis G; Lynn MJ; Frankel MR; Chaturvedi S; Williams JE; Chimowitz M
Stroke; 2009 Mar; 40(3):719-25. PubMed ID: 18832745
[TBL] [Abstract][Full Text] [Related]
7. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study.
Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP;
Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931
[TBL] [Abstract][Full Text] [Related]
8. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
[TBL] [Abstract][Full Text] [Related]
9. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
[TBL] [Abstract][Full Text] [Related]
10. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID.
Kasner SE; Lynn MJ; Chimowitz MI; Frankel MR; Howlett-Smith H; Hertzberg VS; Chaturvedi S; Levine SR; Stern BJ; Benesch CG; Jovin TG; Sila CA; Romano JG;
Neurology; 2006 Oct; 67(7):1275-8. PubMed ID: 17030766
[TBL] [Abstract][Full Text] [Related]
11. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis.
Turan TN; Maidan L; Cotsonis G; Lynn MJ; Romano JG; Levine SR; Chimowitz MI;
Stroke; 2009 Feb; 40(2):505-9. PubMed ID: 19095991
[TBL] [Abstract][Full Text] [Related]
12. Risk factor status and vascular events in patients with symptomatic intracranial stenosis.
Chaturvedi S; Turan TN; Lynn MJ; Kasner SE; Romano J; Cotsonis G; Frankel M; Chimowitz MI;
Neurology; 2007 Nov; 69(22):2063-8. PubMed ID: 18040012
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke.
Khan A; Kasner SE; Lynn MJ; Chimowitz MI;
Stroke; 2012 May; 43(5):1230-3. PubMed ID: 22363054
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting.
Jiang WJ; Yu W; Du B; Gao F; Cui LY
Stroke; 2011 Jul; 42(7):1971-5. PubMed ID: 21636814
[TBL] [Abstract][Full Text] [Related]
16. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis.
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators
Neuroepidemiology; 2003; 22(2):106-17. PubMed ID: 12656117
[No Abstract] [Full Text] [Related]
17. High-sensitive C-reactive protein and dual antiplatelet in intracranial arterial stenosis.
Li J; Wang A; Zhao X; Liu L; Meng X; Lin J; Jing J; Zou X; Wang Y; Wang Y;
Neurology; 2018 Feb; 90(6):e447-e454. PubMed ID: 29330312
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy.
Thijs VN; Albers GW
Neurology; 2000 Aug; 55(4):490-7. PubMed ID: 10953179
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group.
Stroke; 1998 Jul; 29(7):1389-92. PubMed ID: 9660392
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study.
Wang QS; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
Stroke; 2012 Feb; 43(2):346-9. PubMed ID: 22076004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
